2m 2m 2m 2m 2m 2m 2m
MESOBLAST SP ADR (MESO)
NASDAQ
$15.49+$0.010 (+0.06%)
Price as of Sep 11, 2026 7:30 PM EDT- $2.0BMarket Cap
- 4.45%1-Year Change
- BiotechnologyIndustry
MESOBLAST SP ADR (MESO)
$15.49+$0.010 (+0.06%)
Annual
Quarterly
06/30/2026 | 06/30/2025 | 06/30/2024 | 06/30/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 120.3M +599.21% | 17.2M +191.39% | 5.9M -21.32% | 7.5M -26.56% | |
Cost of Revenue | 16.7M +224.89% | 5.1M N/A | N/A N/A | N/A N/A | |
Gross Profit | 103.6M +758.33% | 12.1M +104.47% | 5.9M -21.32% | 7.5M -26.56% | |
Sales and Marketing Expense | 57.3M +45.89% | 39.3M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -97.5M +180.14% | -34.8M +37.29% | -25.4M -6.75% | -27.2M -17.14% | |
Depreciation and Amortization Expense | 8.6M +34.14% | 6.4M +37.16% | 4.7M +13.61% | 4.1M -6.23% | |
Total Operating Expenses | 57.3M +45.89% | 39.3M N/A | N/A N/A | N/A N/A | |
Operating Profit | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -19.9M -8.65% | -21.8M +5.30% | -20.7M +6.24% | -19.4M +15.01% | |
Interest Income and Expense and Net | -19.9M -8.65% | -21.8M +5.30% | -20.7M +6.24% | -19.4M +15.01% | |
Total Nonoperating Income and Expense | 19.9M -8.65% | 21.8M +5.30% | 20.7M +6.24% | 19.4M +15.01% | |
Income before Taxes | -57.5M -43.71% | -102.1M +16.13% | -88.0M +7.41% | -81.9M -10.35% | |
Income Taxes | 613,000 +85.76% | 330,000 +272.77% | -191,000 -9.91% | -212,000 -11.30% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -57.5M -43.71% | -102.1M +16.13% | -88.0M +7.41% | -81.9M -10.35% | |
Net Income from Continuing Operations Applicable to Common | -57.5M -43.71% | -102.1M +16.13% | -88.0M +7.41% | -81.9M -10.35% | |
Basic EPS and Net Income | -0.04 -47.52% | -0.08 -5.05% | -0.09 -19.58% | -0.11 -21.31% | |
Diluted EPS and Net Income | -0.04 -47.52% | -0.08 -5.05% | -0.09 -19.58% | -0.11 -21.31% | |
Basic Weighted Average Shares | 1.3B +7.21% | 1.2B +22.41% | 986.7M +33.51% | 739.0M +13.89% | |
Diluted Weighted Average Shares | 1.3B +7.21% | 1.2B +22.41% | 986.7M +33.51% | 739.0M +13.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 102.9M -36.30% | 161.6M +156.59% | 63.0M -11.72% | 71.3M +17.98% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 102.9M -36.30% | 161.6M +156.59% | 63.0M -11.72% | 71.3M +17.98% | |
Total Current Assets | 197.5M -3.36% | 204.3M +136.34% | 86.5M +5.88% | 81.7M +16.93% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 1.8M +6.82% | 1.7M +53.89% | 1.1M -18.50% | 1.4M -33.64% | |
Total Long-Term Assets | 575.6M -0.82% | 580.3M -0.40% | 582.7M -0.86% | 587.8M -0.77% | |
Total Assets | 773.1M -1.48% | 784.7M +17.27% | 669.2M -0.04% | 669.4M +1.10% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 10.6M -4.99% | 11.2M -19.54% | 13.9M +132.90% | 6.0M +18.64% | |
Total Current Liabilities | 81.1M -20.96% | 102.6M +40.12% | 73.2M +74.46% | 42.0M -18.28% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 123.6M +46.03% | 84.6M -26.78% | 115.6M -7.99% | 125.6M +10.44% | |
Total Liabilities | 204.7M +9.31% | 187.2M -0.82% | 188.8M +12.66% | 167.6M +1.50% | |
Retained Earnings | -1.1B +5.69% | -1.0B +11.24% | -908.8M +10.72% | -820.8M +11.08% | |
Total Stockholders Equity | 1.5B +1.45% | 1.5B +214.11% | 480.4M -4.28% | 501.8M +0.96% | |
Total Shares Outstanding | 1.3B +1.31% | 1.3B +12.15% | 1.1B +40.26% | 813.7M +25.20% | |
Cash Flow | |||||
Cash from Operating Activities | -43.8M -12.26% | -50.0M +3.09% | -48.5M -23.41% | -63.3M -3.82% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.0M -952.50% | 120,000 +223.71% | -97,000 -50.00% | -194,000 -16.38% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -15.3M -110.40% | 147.3M +266.03% | 40.3M -45.97% | 74.5M +854.83% | |
Financials Ratio | |||||
Gross Margin | 86.14% +22.76% | 70.17% N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -7.38% -47.46% | -14.05% +6.92% | -13.14% +6.85% | -12.30% -5.28% | |
Return on Equity | -3.78% -63.16% | -10.27% -42.66% | -17.91% +9.23% | -16.40% -3.21% | |
Revenue Growth | 599.21% +213.08% | 191.39% +997.83% | -21.32% -19.74% | -26.56% -171.81% | |
Current Ratio | 2.43 +22.28% | 1.99 +68.67% | 1.18 -39.31% | 1.95 +43.09% | |
Cash Ratio | 1.27 -19.40% | 1.57 +83.13% | 0.86 -49.40% | 1.70 +44.38% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow